Immunome, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
8.50
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.76
|
-0.75
|
0.01
|
1.32%
|
|
2022-06-30
|
-0.75
|
-0.74
|
0.01
|
1.33%
|
|
2022-03-31
|
-0.69
|
-0.96
|
-0.27
|
-39.13%
|
|
2021-12-31
|
-0.81
|
-0.68
|
0.13
|
16.05%
|
|
2021-09-30
|
-0.50
|
-0.65
|
-0.15
|
-30.00%
|
|
2021-06-30
|
-0.39
|
-0.46
|
-0.07
|
-17.95%
|
|
2021-03-31
|
-0.41
|
-0.37
|
0.04
|
9.76%
|
|
2020-12-31
|
-0.29
|
-0.40
|
-0.11
|
-37.93%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-2.45
|
|
2021-12-31
|
-2.16
|
|
2020-12-31
|
-8.50
|